WISE-2005: reduced cerebral blood flow velocity with nitroglycerin--comparison with common carotid artery blood flow.
During the WISE-2005 study of 24 women, we observed a reduction (21.6 +/- 0.89%, mean +/- SEM) in cerebral blood flow velocity (CBV) measured by transcranial Doppler ultrasound, following 0.3 mg sublingual nitroglycerin (NG). In parallel, we observed quantitative reductions in leg blood flow (47.3 +/- 7.0%) and corresponding reductions in calculated conductance (Conductance = Femoral Flow / Mean Arterial Pressure; 45.7 +/- 7.2%). To determine if the reduction in CBV was the result of reduced cerebral blood flow or dilation of the middle cerebral artery (MCA), the change in CBV in the MCA was compared with changes in quantitative flow measured in the common carotid artery (CCA). The relationship between CBV and CCA blood flow was tested in five men and four women using hyper- and hypo-ventilation to manipulate arterial PCO2. Changes in CCA blood flow were positively correlated with changes in CBV (p<0.001). We then investigated the CBV and CCA flow responses to sublingual NG in an additional two men and six women. Concurrent with the reduction in CBV there was no change in blood flow through the CCA (p>0.05). These results indicate that the decrease in CBV observed in response to NG was probably the result of dilation of the MCA and that total cerebral blood flow was similar after administration of NG. These results suggest regional differences in the vascular responses to NG during the WISE bed rest. Conduit vessels of both the peripheral and cerebral vasculature dilated; however, the resistance vessels in skeletal muscle constricted causing a reduction in blood flow, while the resistance vessels of the brain appeared to be unaffected by NG so that cerebral blood flow remained constant. These results highlight the need to obtain quantitative measures of cerebral blood flow if there is reason to suspect that the diameter of the MCA might not remain constant.
Zuj
K A
KA
Cardiorespiratory & Vascular Dynamics Lab, Univ. Waterloo, Waterloo, Ontario, Canada. Kathryn.Zuj@gmail.com
Greaves
D K
DK
Hughson
R L
RL
D000286:Administration, Sublingual; D000328:Adult; D001510:Bed Rest / Q000009:adverse effects*; D001783:Blood Flow Velocity / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D018493:Cardiovascular Deconditioning; D017536:Carotid Artery, Common / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004244:Dizziness / Q000097:blood / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology*; D005260:Female; D018475:Head-Down Tilt; D006801:Humans; D008297:Male; D020768:Middle Cerebral Artery / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D005996:Nitroglycerin / Q000008:administration & dosage*; D012039:Regional Blood Flow / Q000187:drug effects; D013026:Space Flight; D013997:Time Factors; D014463:Ultrasonography; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage*; D018474:Weightlessness Simulation
D014665:Vasodilator Agents; D002245:Carbon Dioxide; D005996:Nitroglycerin